1-6 of 6
Nathan Hall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

Clinical Trials & Observations
Heiko Schöder, Mei-Yin C. Polley, Michael V. Knopp, Nathan Hall, Lale Kostakoglu, Jun Zhang, Howard R. Higley, Gary Kelloff, Heshan Liu, Andrew D. Zelenetz, Bruce D. Cheson, Nina Wagner-Johnston, Brad S. Kahl, Jonathan W. Friedberg, Eric D. Hsi, John P. Leonard, Lawrence H. Schwartz, Wyndham H. Wilson, Nancy L. Bartlett
Journal: Blood
Blood (2020) 135 (25): 2224–2234.
https://doi.org/10.1182/blood.2019003277
Published: 2020
Includes: Supplemental data
Journal Articles

Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study

Clinical Trials & Observations
Samantha M. Jaglowski, Jeffrey A. Jones, Veena Nagar, Joseph M. Flynn, Leslie A. Andritsos, Kami J. Maddocks, Jennifer A. Woyach, Kristie A. Blum, Michael R. Grever, Kelly Smucker, Amy S. Ruppert, Nyla A. Heerema, Gerard Lozanski, Mona Stefanos, Brian Munneke, Jamie-Sue West, Jutta K. Neuenburg, Danelle F. James, Nathan Hall, Amy J. Johnson, John C. Byrd
Journal: Blood
Blood (2015) 126 (7): 842–850.
https://doi.org/10.1182/blood-2014-12-617522
Published: 2015
Includes: Supplemental data
Journal Articles

Interim FDG PET Imaging in CALGB 50203 Trial of Stage I/II Non-Bulky Hodgkin Lymphoma: Would Using Combined PET and CT Criteria Better Predict Response Than Each Test Alone?,

Lale Kostakoglu, MD, MPH, Heiko Schoder, MD, Nathan Hall, MD, PhD, David J. Straus, MD, Jeffrey L Johnson, PhD, Lawrence Schwartz, MD, Ann LaCasce, MD, Sin-Ho Jung, PhD, Nancy L. Bartlett, MD, George P. Canellos, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2011) 118 (21): 3644.
https://doi.org/10.1182/blood.V118.21.3644.3644
Published: 2011
Journal Articles

The Prognostic Value of FDG PET/CT Prior to Autologous Stem Cell Transplant in Mantle Cell Lymphoma

Jonathon B. Cohen, MD, Nathan Hall, MD, PhD, Amy S. Ruppert, MAS, Jeffrey A. Jones, MD, MPH, Pierluigi Porcu, MD, Robert A. Baiocchi, M.D., Ph.D., Sam Penza, MD, Don M Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Joseph M. Flynn, DO, MPH, Steven M. Devine, MD, Kristie A Blum, MD
Journal: Blood
Blood (2011) 118 (21): 3113.
https://doi.org/10.1182/blood.V118.21.3113.3113
Published: 2011
Journal Articles

Validation of the International Harmonization Project (IHP) Guidelines in Early Stage Hodgkin Lymphoma (HL) Treated with Adriamycin, Vinblastine and Gemcitabine (AVG) (CALGB 50203): Early Results.

Lale Kostakoglu, MD, MPH, David J. Straus, MD, Heiko Schöder, MD, Ann S. LaCasce, MD, Nancy L Bartlett, MD, Nathan Hall, MD, PhD, Jeffrey L Johnson, PhD, Sin-Ho Jung, PhD, George P. Canellos, MD, Lawrence H Schwartz, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2008) 112 (11): 1460.
https://doi.org/10.1182/blood.V112.11.1460.1460
Published: 2008
Journal Articles

Doxorubicin, Vinblastine and Gemcitabine (AVG), a Novel Regimen Excluding Bleomycin for the Treatment of Early Stage Hodgkin Lymphoma (HL): Results of CALGB 50203.

David Straus, MD, Ann LaCase, MD, Malik Juweid, MD, Lale Kostakogolu, MD, Nathan Hall, MD, Jeffery Johnson, MS, Sin-Ho Jung, Ph.D., George Canellos, MD, Lawrence Schwartz, MD, Bruce Cheson, MD
Journal: Blood
Blood (2007) 110 (11): 214.
https://doi.org/10.1182/blood.V110.11.214.214
Published: 2007